Clinical bottom line
The use of probiotics for the prevention of allergic diseases in infants is an area of active research with promising but mixed results. While some studies suggest potential benefits in reducing the risk of eczema and other allergic conditions, the evidence is not yet robust enough to support routine clinical recommendations. Clinicians should consider individual patient factors and emerging evidence when discussing probiotics with parents.
What the evidence shows
Recent systematic reviews and meta-analyses have evaluated the role of probiotics in preventing allergic diseases in infants. A 2020 meta-analysis found that certain probiotic strains may reduce the risk of eczema in infants, particularly when administered prenatally to mothers and postnatally to infants [1]. Another study highlighted that the timing, duration, and specific strains of probiotics are critical factors influencing outcomes [2]. However, a 2021 Cochrane review concluded that while there is some evidence supporting the use of probiotics for eczema prevention, the overall quality of evidence is low, and the results are inconsistent across studies [3].
Caveats and uncertainty
Despite promising findings, several caveats remain. The heterogeneity in study designs, probiotic strains, dosages, and populations makes it challenging to draw definitive conclusions. The long-term safety of probiotic use in infants is not fully established, and there is variability in regulatory standards for probiotic products. Additionally, the mechanisms by which probiotics might prevent allergic diseases are not completely understood, necessitating further research to elucidate these pathways.
How this may change practice
While current evidence does not support routine probiotic supplementation for all infants to prevent allergic diseases, it may be considered in specific cases, such as infants at high risk for allergies. Clinicians should stay informed about ongoing research and emerging guidelines to provide evidence-based recommendations. As more high-quality trials are conducted, the role of probiotics in allergy prevention may become clearer, potentially influencing future clinical practices.